Vitality Watch

Dossier clinicaltrials trial early 11-aug-2026
Small or early-phase human trial or pilot study

Sarcopenia in Chronic Kidney Disease (CKD) Patients

Key claim: A clinical study will test whether two amino acids can practically improve muscle mass and strength in advanced CKD patients who cannot follow the usual high-protein sarcopenia diet.

Abstract

Sarcopenia, or loss of muscle and strength is common in patients with poor kidney function. Although a high protein diet is generally recommended for sarcopenia, patients with poor kidney function are advised to follow a low-protein diet. In this study, we will evaluate the practicality and potential benefits of two different amino acids (molecules that form proteins) in improving sarcopenia in patients with advanced kidney disease.

The study aims to improve muscle mass and strength. All study procedures are free of cost and do not require significant time commitment. You will have time to ask questions and discuss the study with your family, primary care physician, and your kidney doctor to make the decision if this is right study for you to participate in.

Why this matters

A clinical study will test whether two amino acids can practically improve muscle mass and strength in advanced CKD patients who cannot follow the usual high-protein sarcopenia diet.

Source

Link

Briefing card

Sarcopenia in Chronic Kidney Disease (CKD) Patients
Stage: trial early · clinicaltrials · 11-aug-2026

A clinical study will test whether two amino acids can practically improve muscle mass and strength in advanced CKD patients who cannot follow the usual high-protein sarcopenia diet.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07437053

build build 880 · 2bcef25 · 2026-11-18